| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043042992 |
| P356 | DOI | 10.1038/NM.3935 |
| P3181 | OpenCitations bibliographic resource ID | 1657054 |
| P932 | PMC publication ID | 4886231 |
| P698 | PubMed publication ID | 26340119 |
| P2093 | author name string | Guoping Feng | |
| Tobias Kaiser | |||
| P2860 | cites work | A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterations | Q48959451 |
| Altered default mode and fronto-parietal network subsystems in patients with schizophrenia and their unaffected siblings. | Q50652153 | ||
| Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. | Q51899338 | ||
| Structural and functional evolution of the basal ganglia in vertebrates | Q57540064 | ||
| Translating cancer research into targeted therapeutics | Q59060386 | ||
| Genetics of autism spectrum disorders | Q84797519 | ||
| Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication | Q21198697 | ||
| CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila | Q24315560 | ||
| Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments | Q24328996 | ||
| Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function | Q24338263 | ||
| Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
| Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3 | Q24596677 | ||
| Shank3 mutant mice display autistic-like behaviours and striatal dysfunction | Q24597501 | ||
| Common genetic variants on 5p14.1 associate with autism spectrum disorders | Q24603204 | ||
| Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses | Q24610600 | ||
| A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice | Q24629938 | ||
| Modelling schizophrenia using human induced pluripotent stem cells | Q24633007 | ||
| Disruption of the neurexin 1 gene is associated with schizophrenia | Q24647095 | ||
| Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior | Q24679793 | ||
| Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors | Q26269833 | ||
| The study of psychiatric disease genes and drugs in zebrafish | Q26824671 | ||
| Genome-scale neurogenetics: methodology and meaning | Q26859474 | ||
| High resolution magnetic resonance imaging for characterization of the neuroligin-3 knock-in mouse model associated with autism spectrum disorder | Q27336312 | ||
| Epigenetics of Stress-Related Psychiatric Disorders and Gene × Environment Interactions | Q28083023 | ||
| Heritability estimates for psychotic disorders: the Maudsley twin psychosis series | Q28137629 | ||
| The endophenotype concept in psychiatry: etymology and strategic intentions | Q28187744 | ||
| Synaptic scaffolding proteins in rat brain. Ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein alpha-fodrin | Q28213213 | ||
| Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche | Q28239639 | ||
| Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2 | Q28268807 | ||
| SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients | Q28300343 | ||
| AMPAKINE enhancement of social interaction in the BTBR mouse model of autism | Q28388762 | ||
| FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders | Q28973611 | ||
| Cerebral organoids model human brain development and microcephaly | Q28973619 | ||
| Research domain criteria (RDoC): toward a new classification framework for research on mental disorders | Q29547877 | ||
| Autism-like behavioral phenotypes in BTBR T+tf/J mice | Q29615512 | ||
| A new initiative on precision medicine | Q29615654 | ||
| Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease | Q29615682 | ||
| Self-organizing optic-cup morphogenesis in three-dimensional culture | Q29616181 | ||
| Structural and molecular interrogation of intact biological systems | Q29616195 | ||
| Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice | Q29616328 | ||
| Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits | Q29618411 | ||
| Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia | Q29618963 | ||
| Animal models of neuropsychiatric disorders | Q29619899 | ||
| A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells | Q29619964 | ||
| Stepwise evolution of stable sociality in primates | Q30085655 | ||
| Wild-type microglia arrest pathology in a mouse model of Rett syndrome | Q30424614 | ||
| Mouse models of gene-environment interactions in schizophrenia | Q30432026 | ||
| Loss of predominant Shank3 isoforms results in hippocampus-dependent impairments in behavior and synaptic transmission | Q30438299 | ||
| SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties | Q30438816 | ||
| Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice | Q30461096 | ||
| Gamma frequency-range abnormalities to auditory stimulation in schizophrenia | Q30481594 | ||
| Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome | Q30529349 | ||
| Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors | Q30561087 | ||
| Repeated cortico-striatal stimulation generates persistent OCD-like behavior | Q30574071 | ||
| FAAH genetic variation enhances fronto-amygdala function in mouse and human | Q30625337 | ||
| A review of diffusion tensor imaging studies in schizophrenia | Q30994764 | ||
| Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. | Q31966529 | ||
| Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder | Q33181070 | ||
| Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. | Q33685348 | ||
| Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia | Q33829829 | ||
| Prioritization of neurodevelopmental disease genes by discovery of new mutations | Q33830995 | ||
| The basal ganglia | Q33970931 | ||
| A polygenic burden of rare disruptive mutations in schizophrenia | Q34060200 | ||
| Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. | Q34214883 | ||
| Regionally localized thinning of the cerebral cortex in schizophrenia | Q34229033 | ||
| Thalamic dysfunction in schizophrenia suggested by whole-night deficits in slow and fast spindles | Q34268494 | ||
| Neural synchrony indexes disordered perception and cognition in schizophrenia | Q34368405 | ||
| Clinical development success rates for investigational drugs | Q34396786 | ||
| Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders | Q34401694 | ||
| Comparative study of human and mouse postsynaptic proteomes finds high compositional conservation and abundance differences for key synaptic proteins | Q34447339 | ||
| Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons | Q34469459 | ||
| De novo mutations in schizophrenia implicate synaptic networks | Q34540372 | ||
| Gene-environment interactions in psychiatry: joining forces with neuroscience | Q34540742 | ||
| Abnormal medial prefrontal cortex resting-state connectivity in bipolar disorder and schizophrenia | Q35171332 | ||
| A role for glia in the progression of Rett's syndrome | Q35712588 | ||
| From circuits to behaviour in the amygdala | Q36045805 | ||
| Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method | Q36050571 | ||
| Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. | Q36061657 | ||
| Learning From Animal Models of Obsessive-Compulsive Disorder | Q36249163 | ||
| Wild-type microglia do not reverse pathology in mouse models of Rett syndrome | Q36386922 | ||
| Reduced sleep spindles and spindle coherence in schizophrenia: mechanisms of impaired memory consolidation? | Q36580050 | ||
| Forward frontal fields: phylogeny and fundamental function | Q36984777 | ||
| Cortical source estimates of gamma band amplitude and phase are different in schizophrenia | Q37086990 | ||
| Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior | Q37250051 | ||
| A genome-wide linkage and association scan reveals novel loci for autism | Q37410600 | ||
| Identifying essential cell types and circuits in autism spectrum disorders. | Q37500060 | ||
| Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism | Q37716254 | ||
| Genetic architecture in autism spectrum disorder | Q37998609 | ||
| Brain-mapping projects using the common marmoset | Q38255163 | ||
| Genetic analysis of schizophrenia and bipolar disorder reveals polygenicity but also suggests new directions for molecular interrogation | Q38301816 | ||
| Animal model of depression. I. Review of evidence: implications for research | Q40013217 | ||
| Synaptic dysregulation in a human iPS cell model of mental disorders | Q41534293 | ||
| Evolutionary conservation of the basal ganglia as a common vertebrate mechanism for action selection | Q42490452 | ||
| Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study | Q42632778 | ||
| Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case | Q43449419 | ||
| Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study | Q44252090 | ||
| Effect of riluzole on MK-801 and amphetamine-induced hyperlocomotion | Q44529350 | ||
| Psychiatric endophenotypes and the development of valid animal models. | Q45920656 | ||
| Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo | Q48170047 | ||
| Medicine. Brain disorders? Precisely | Q48199146 | ||
| Wireless magnetothermal deep brain stimulation | Q48283798 | ||
| Architectural subdivisions of medial and orbital frontal cortices in the marmoset monkey (Callithrix jacchus). | Q48717272 | ||
| Striatal volume on magnetic resonance imaging and repetitive behaviors in autism | Q48866759 | ||
| Impaired long-term depression in schizophrenia: a cathodal tDCS pilot study | Q48881014 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 979-88 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Modeling psychiatric disorders for developing effective treatments | |
| P478 | volume | 21 |
| Q42247782 | A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing |
| Q37624658 | Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models |
| Q38735486 | An update on stem cell biology and engineering for brain development |
| Q63979723 | Analysis of Neuropsychiatric Disease-Related Functional Neuroanatomical Markers in Mice |
| Q42702891 | Animal models for bipolar disorder: from bedside to the cage. |
| Q97537847 | Behavioral tests assessing neuropsychiatric phenotypes in adolescent mice reveal strain- and sex-specific effects |
| Q27317789 | Behavioural traits propagate across generations via segregated iterative-somatic and gametic epigenetic mechanisms |
| Q57456677 | Cathepsin B inhibition ameliorates leukocyte-endothelial adhesion in the BTBR mouse model of autism |
| Q30364171 | Contributions of the Central Extended Amygdala to Fear and Anxiety. |
| Q41665354 | Cross Talk: The Microbiota and Neurodevelopmental Disorders |
| Q47895125 | Developmental timing and critical windows for the treatment of psychiatric disorders. |
| Q30368900 | Dispositional negativity: An integrative psychological and neurobiological perspective |
| Q52682637 | Dynamic Changes of the Mitochondria in Psychiatric Illnesses: New Mechanistic Insights From Human Neuronal Models. |
| Q93356231 | Early Correction of N-Methyl-D-Aspartate Receptor Function Improves Autistic-like Social Behaviors in Adult Shank2-/- Mice |
| Q52328697 | Excitatory and inhibitory synaptic dysfunction in mania: an emerging hypothesis from animal model studies. |
| Q37740652 | From Engrams to Pathologies of the Brain |
| Q28604315 | Genetic and Environmental Contributions to Functional Connectivity Architecture of the Human Brain |
| Q38726048 | Human dermal fibroblasts in psychiatry research |
| Q55404711 | Hyperactivity and Hypermotivation Associated With Increased Striatal mGluR1 Signaling in a Shank2 Rat Model of Autism. |
| Q30829127 | Hyperconnectivity of prefrontal cortex to amygdala projections in a mouse model of macrocephaly/autism syndrome |
| Q36851161 | Innovative approaches to bipolar disorder and its treatment |
| Q30358363 | Marmosets: A Neuroscientific Model of Human Social Behavior. |
| Q38676860 | Methodological issues associated with preclinical drug development and increased placebo effects in schizophrenia clinical trials. |
| Q92940436 | Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences |
| Q42373035 | Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome |
| Q94562321 | Multiplex precise base editing in cynomolgus monkeys |
| Q36930992 | News Feature: Better models for brain disease |
| Q38826903 | Opportunities and challenges in modeling human brain disorders in transgenic primates |
| Q92524935 | Probing disrupted neurodevelopment in autism using human stem cell-derived neurons and organoids: An outlook into future diagnostics and drug development |
| Q93112539 | Process-based framework for precise neuromodulation |
| Q95561626 | Reprogramming psychiatry: stem cells and bipolar disorder |
| Q46766704 | SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons |
| Q28272545 | Schizophrenia risk from complex variation of complement component 4 |
| Q37397249 | Sustained synchronized neuronal network activity in a human astrocyte co-culture system. |
| Q46092660 | The central extended amygdala in fear and anxiety: Closing the gap between mechanistic and neuroimaging research |
| Q90441765 | The future of rodent models in depression research |
| Q100946502 | The gut microbiota-brain axis in behaviour and brain disorders |
| Q38775856 | The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes |
| Q37458611 | The neurobiology of dispositional negativity and attentional biases to threat: Implications for understanding anxiety disorders in adults and youth |
| Q38992286 | The road to precision psychiatry: translating genetics into disease mechanisms. |
| Q38636780 | Three-Dimensional Models of the Human Brain Development and Diseases |
| Q38699013 | Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies. |
| Q54961637 | Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders. |
| Q46438784 | Why marmosets? |
Search more.